Jin Zhipeng, Guo Tianyu, Zhang Xue, Wang Xin, Liu Yefu
Department of Hepatopancreatobiliary Surgery, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, China.
Central Laboratory, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, China.
Front Oncol. 2024 Oct 15;14:1448695. doi: 10.3389/fonc.2024.1448695. eCollection 2024.
Protein tyrosine kinase 7 (PTK7) is an evolutionarily conserved transmembrane receptor and a specialized tyrosine kinase protein lacking kinase activity. PTK7 has been found to be strongly associated with a variety of diseases, including cancer. In this review, we will provide a comprehensive overview of the involvement of PTK7 in human cancer, focusing on the changing research landscape of PTK7 in cancer research, the molecular mechanisms of PTK7 involved in cancer progression, the targetability of PTK7 in cancer therapy, and the potential application of PTK7 in cancer management, thus demonstrating that PTK7 may be an underestimated contributor to human cancer.
蛋白酪氨酸激酶7(PTK7)是一种进化上保守的跨膜受体,是一种缺乏激酶活性的特殊酪氨酸激酶蛋白。已发现PTK7与多种疾病密切相关,包括癌症。在本综述中,我们将全面概述PTK7在人类癌症中的作用,重点关注PTK7在癌症研究中不断变化的研究格局、PTK7参与癌症进展的分子机制、PTK7在癌症治疗中的可靶向性以及PTK7在癌症管理中的潜在应用,从而表明PTK7可能是人类癌症中一个被低估的因素。